Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin-Reply

Affiliations

¹ International Diabetes Center, Park Nicollet Internal Medicine, Minneapolis, Minnesota.
² Jaeb Center for Health Research Foundation Inc, Tampa, Florida.
³ International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota.

Comment

Thomas W Martens et al. JAMA. 2021.

. 2021 Oct 5;326(13):1330-1331.

doi: 10.1001/jama.2021.13478.

¹ International Diabetes Center, Park Nicollet Internal Medicine, Minneapolis, Minnesota.
² Jaeb Center for Health Research Foundation Inc, Tampa, Florida.
³ International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota.

No abstract available

Comment on

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.
Cowart K, Carris NW. Cowart K, et al. JAMA. 2021 Oct 5;326(13):1329-1330. doi: 10.1001/jama.2021.13472. JAMA. 2021. PMID: 34609458 No abstract available.
US Preventive Services Task Force Recommendation Statement on Screening for Colorectal Cancer.
Haghighat S, Sussman DA, Deshpande A. Haghighat S, et al. JAMA. 2021 Oct 5;326(13):1328. doi: 10.1001/jama.2021.13466. JAMA. 2021. PMID: 34609459 No abstract available.